BioTech Life Science Pharmaceuticals Primary Care 
Healthcare IT Today
JANUARY 8, 2024
It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.
Lloyd Price
SEPTEMBER 2, 2023
Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.
Expert insights. Personalized for you.
81 
Let's personalize your content